Ann: Appendix 4C - quarterly, page-23

Imagine company only focusing on African swine fever and have come up with a solution to it, I think that alone is justified for a 100m Mcap, and then you have the 10m $ turtle wax deal in the coming years inked, then another 10-20 deals worth on average some millions. I think we very well should have a Mcap of closer to 200million as we are now, especially with sooo many negotiations taking place which should become signed deals anytime now.
And now they tell us they are going after SARS, with government trials.

97m Mcap is cheappppp.